And the downregulation of the SP1/Syncytin-1 axis can reverse the epithelial-mesenchymal transition process by inhibiting the activity of Akt and Erk1/2 signal pathways in NSCLC cells, inhibiting cell proliferation and migration, promoting cell apoptosis [125]. The gene discussed is SP1; the disease is non-small cell lung carcinoma.